significant improvements in longevity and quality of life. In our Research and Development Center, the staff members are senior researchers and distinguished scientists with many publications in high-impact journals and published books, focusing on Cross-Field research areas, including (but not limited to) subtopics like Big Data Analysis, IoT, Artificial Intelligence, Agriculture, Computational Biomedicine, Bioinformatics, Neuroinformatics, Bayesian Statistics, Cancer, developing medical decision support systems, predictive algorithms, and diagnostic tools in neurodegenerative diseases, identifying molecular mechanisms of infectious diseases, Immunopharmacology, Nanotechnology, Psychology, Special Education, Digital Education, and Bioethics.

Funogen has an active and successful collaboration with several institutions worldwide, leading to joint publications and projects.

Nowadays, focusing primarily on Autism Spectrum Disorder and Alzheimer’s Disease, Funogen’s Biomedical Department works on identifying new, efficient, non-invasive, and low-cost biomarkers to improve the ‘Aging Cure and Care’ inside Europe and globally. New software that will detect Alzheimer’s severity via the assessment of stimuli is under modeling, designing, and production.

Our team is working on using enrichment environments to correlate brain activity, brain waves, and consciousness or unconscious behavior. Our efforts will help to reduce social inequalities, eliminate alienation phenomena, and study ways of integrating isolated people into social environments.